A multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred Diethylstilbestrol
about
Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate CancerGlucocorticoids and prostate cancer treatment: friend or foe?Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.End points of clinical trials in metastatic castration-resistant prostate cancer: A systematic reviewDiethylstilboestrol for the treatment of prostate cancer: past, present and future.Assessment of anticancer-treatment outcome in patients with metastatic castration-resistant prostate cancer-going beyond PSA and imaging, a systematic literature review.Managing Metastatic Castration-Resistant Prostate Cancer in the Pre-chemotherapy Setting: A Changing Approach in the Era of New Targeted Agents.The role of glucocorticoid receptor in prostate cancer progression: from bench to bedside.Reappraisal of glucocorticoids in castrate-resistant prostate cancerAntitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer.Reply: 'Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'.Comment on 'Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'.Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials.Androgen receptor reverts dexamethasone‑induced inhibition of prostate cancer cell proliferation and migration.The efficacy and safety of docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration: JMTO Pca 10-01 phase II trial.[Corticosteroids in the management of advanced prostate cancer].Drug Repositioning for Effective Prostate Cancer Treatment.
P2860
Q28067556-7F538C95-5782-443E-A991-E1034797398CQ33621387-585501F3-14D4-49CA-A957-6AA09004A321Q34315605-744E30A9-3017-468D-9E5E-5B9CDB05F87CQ34367585-9E738C7E-7C43-4AD0-84A0-1CF951FE7E82Q34386403-C339B5F8-DD69-47D6-A033-524FB8F35C9BQ38555581-09DFB097-F0AE-4BDE-8711-61A1D6FD89FBQ38731861-368CC99C-9D13-4BE9-9EEE-0D3B0D66EBF9Q39041932-40B3A130-D075-4BD9-8412-908BE7C23A22Q42139962-9517C509-3C75-4504-842D-0ACF931036DAQ42641870-DA7A6123-2AC4-42CC-B2E6-71C9E6B104C2Q42748594-D2B1FC03-9BF9-4D3A-88C1-5D3A539BF123Q42748595-3F64C3FB-C6E1-4EBC-A363-87509A2C3EB1Q47644799-8A10FA92-DE0E-4556-95D9-0363424650BCQ50047876-90A11582-6F8F-46F7-9184-D4F09C8C70A6Q50978342-7DAF93A1-CCD4-42D0-9A7C-6C7BE144790BQ53760482-2767499D-CDBC-43D2-B27B-D961B22CD465Q55254671-A1EBDB2F-08BA-4563-9861-D43FEAD8A4C5
P2860
A multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred Diethylstilbestrol
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A multi-centre randomised phas ...... vs deferred Diethylstilbestrol
@ast
A multi-centre randomised phas ...... vs deferred Diethylstilbestrol
@en
A multi-centre randomised phas ...... vs deferred Diethylstilbestrol
@nl
type
label
A multi-centre randomised phas ...... vs deferred Diethylstilbestrol
@ast
A multi-centre randomised phas ...... vs deferred Diethylstilbestrol
@en
A multi-centre randomised phas ...... vs deferred Diethylstilbestrol
@nl
prefLabel
A multi-centre randomised phas ...... vs deferred Diethylstilbestrol
@ast
A multi-centre randomised phas ...... vs deferred Diethylstilbestrol
@en
A multi-centre randomised phas ...... vs deferred Diethylstilbestrol
@nl
P2093
P2860
P356
P1476
A multi-centre randomised phas ...... vs deferred Diethylstilbestrol
@en
P2093
A Protheroe
S J Sarker
P2860
P2888
P304
P356
10.1038/BJC.2011.7
P407
P50
P577
2011-02-01T00:00:00Z
P5875
P6179
1041878352